Compare SMBC & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SMBC | BVS |
|---|---|---|
| Founded | 1887 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 742.0M | 617.1M |
| IPO Year | 2011 | 2016 |
| Metric | SMBC | BVS |
|---|---|---|
| Price | $69.49 | $10.95 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $69.50 | $14.00 |
| AVG Volume (30 Days) | 98.2K | ★ 408.4K |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.47% | N/A |
| EPS Growth | 17.19 | ★ 163.46 |
| EPS | ★ 3.00 | 0.04 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | $16.09 | $7.52 |
| Revenue Next Year | $5.69 | $7.06 |
| P/E Ratio | ★ $22.92 | $32.36 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $47.60 | $5.81 |
| 52 Week High | $70.10 | $10.76 |
| Indicator | SMBC | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 61.73 | 70.60 |
| Support Level | $63.78 | $8.27 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 1.78 | 0.50 |
| MACD | 0.02 | 0.06 |
| Stochastic Oscillator | 82.55 | 92.80 |
Southern Missouri Bancorp Inc is a USA-based holding company for Southern Missouri Savings Bank. The principal business of the bank consists of attracting retail deposits from the general public and using such deposits along with wholesale funding from the Federal Home Loan Bank of Des Moines, and to a lesser extent, brokered deposits, to invest in one- to four-family residential mortgage loans, mortgage loans secured by commercial real estate, commercial non-mortgage business loans, and consumer loans. It is engaged in providing the range of banking and financial services to individuals and corporate customers in its market areas. The company derives revenue principally from interest earned on loans, debt securities, bank card interchange fees, loan late charges and another fee income.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.